|
EP2979688A1
|
|
Composition containing Apomorphine and a Divalent Metal Cation
|
|
DE102013007389A1
|
|
Drug delivery device
|
|
TW201249424A
|
|
Apparatus and case for infusion equipment
|
|
EP2545905A1
|
|
A new therapeutical composition containing apomorphine as active ingredient
|
|
GB201009812D0
|
|
Portable case for infusion
|
|
GB0803968D0
|
|
Improved phospholipid and method for its production
|
|
GB0803969D0
|
|
Improved phospholipid and method for its production
|
|
GB0800616D0
|
|
Use of phospholipids as a selective pulmonary barrier layer
|
|
GB0715285D0
|
|
Improvements in or relating to powdered medicaments for nasal delivery
|
|
GB0703278D0
|
|
Improved phospholipid and method for its production
|
|
GB0703277D0
|
|
Improved phospholipid and method for its production
|
|
GB0700366D0
|
|
Use of phospholipids as a selective pulmonary barrier layer
|
|
GB0613841D0
|
|
Injectable pharmaceutical compositions containing panthenol
|
|
WO2006125970A2
|
|
Phospholipids for use in the treatment of an allergic inflammatory condition
|
|
GB0600131D0
|
|
Use of phospholipids as a selective pulmonary barrier layer
|
|
GB0500677D0
|
|
Dry powder inhaler
|
|
GB0500478D0
|
|
Use of phospholipids as a selective pulmonary barrier layer
|
|
GB0426010D0
|
|
Improvements in or relating to organic materials
|
|
GB0411502D0
|
|
Pharmaceutical compositions
|
|
GB0404586D0
|
|
Improvements in or relating to organic materials
|
